15 Best Large-Cap Value Stocks to Buy in 2025

Page 7 of 14

8. Elevance Health, Inc. (NYSE:ELV)

Analyst Upside as of January 20, 2025: 31%

Number of Hedge Fund Holders: 67

Elevance Health, Inc. (NYSE:ELV) is a prominent health benefits company in the United States. In the third quarter of 2024, Elevance Health, Inc. (NYSE:ELV) generated revenue worth $44.7 billion, up by 2.2%, and an adjusted operating gain of $2.4 billion. In addition to that, the company generated an operating cash flow worth $2.7 billion year-to-date, an increase of $0.1 billion year-over-year.

The company is extremely confident in its long-term potential to expand its earnings growth, especially in the Medicaid business. The company is committed to providing affordable Medicaid solutions to members and improving operational efficiencies immensely, explaining its ranking on our list and popularity among hedge funds. Overall, the company’s financial results were driven by its diversified portfolio and the efficient execution of its strategic initiatives.

Elevance Health, Inc. (NYSE:ELV) has strong fundamentals positioning it as an important name in the industry. On January 16, Andrew Mok CFA from Barclays maintained a buy rating on ELV with a price target of $501.

Page 7 of 14